Investors Encouraged to Take Lead in Securities Fraud Lawsuit Against Microvast Holdings

LOS ANGELES, January 3, 2024 /PRNewswire/ — Investors who have suffered significant losses due to securities fraud have the opportunity to lead a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST). The law firm Glancy Prongay & Murray LLP (GPM) has announced that it is seeking lead plaintiffs for the case.

The class period for the lawsuit runs from October 19, 2022, to November 20, 2023. Investors interested in serving as lead plaintiff can submit their contact information at www.glancylaw.com/cases/Microvast-Holdings-Inc/. They can also reach out to Charles H. Linehan of GPM at 310-201-9150 or toll-free at 888-773-9224, or via email at [email protected]

According to the complaint filed, Defendants allegedly failed to disclose key information to investors during the class period. This includes the fact that there was a likelihood that Microvast would not be awarded a grant after due diligence was performed, as well as the cessation of negotiations and rescission of the grant. The complaint also alleges that the company misrepresented the nature and profitability of its businesses and partnerships. As a result, the defendants’ positive statements about the company’s prospects were misleading or lacked a reasonable basis.

Glancy Prongay & Murray LLP is encouraging investors to follow the firm on LinkedIn, Twitter, and Facebook for updates regarding the case.

Investors who wish to join the class action do not need to take any immediate action. They have the option to retain their own legal counsel or choose not to participate and remain as absent members of the lawsuit. Those who have questions or want more information about the class action can contact Charles Linehan, Esquire, of GPM by calling 310-201-9150 or toll-free at 888-773-9224. They can also send an email to [email protected] or visit www.glancylaw.com.

Please note that this press release may be considered Attorney Advertising in some jurisdictions under applicable law and ethical rules.

Source: Glancy Prongay & Murray LLP